Jotin Marango
CIK 1777513 · Chief Financial Officer · last filed 2025-07-29
Jotin Marango is a Chief Financial Officer who has filed 14 SEC Form 4 insider transactions across 3 companies since 2019. The most recent filing, for IMA, was dated Jul 29, 2025. Across all open-market trades the lifetime net is −$512.9K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $62.6K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$62.6K
3
14
-$512.9K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| IMA | Chief Financial Officer | 11,146 | $5.62 | $62.6K | $0 | 1 | 2025-07-29 |
| ImageneBio, Inc. (IKNA) Delisted | CFO & Head of Corp. Dev. | — | $17.16 | — | $0 | 3 | 2024-02-02 |
| Aptose Biosciences Inc. (APTO) Delisted | Senior VP, CFO, and CBO | 116,219 | $1.71 | $198.7K | -$512.9K | 10 | 2022-01-20 |
Recent Filings
14 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-07-29 | IMA | Mixed | +11,146 | -$79.5K | EDGAR |
| 2024-02-02 | ImageneBio, Inc. (IKNA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-01-05 | ImageneBio, Inc. (IKNA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-04-25 | ImageneBio, Inc. (IKNA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-01-20 | Aptose Biosciences Inc. (APTO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-08-23 | Aptose Biosciences Inc. (APTO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-01-06 | Aptose Biosciences Inc. (APTO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-07-10 | Aptose Biosciences Inc. (APTO) Delisted | Sell (S) | −62,835 | -$380.2K | EDGAR |
| 2020-07-02 | Aptose Biosciences Inc. (APTO) Delisted | Sell (S) | −20,946 | -$132.8K | EDGAR |
| 2020-05-07 | Aptose Biosciences Inc. (APTO) Delisted | Grant (A) | +120,000 | $0 | EDGAR |